CTA056 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

CTA 056 possesses high inhibitory effects toward interleukin-2-inducible T-cell kinase (Itk), Bruton’s tyrosine kinase and endothelial and epithelial tyrosine kinase. Also, it targets acute lymphoblastic T-cell leukemia and cutaneous T-cell lymphoma.

CTA056 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

CTA056 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Aladdin Scientific	+1-+1(833)-552-7181	sales@aladdinsci.com	United States	52924	58
Shanghai Hongye Biotechnology Co. Ltd	400-9205774	sales@glpbio.cn	China	6777	58
TargetMol Chemicals Inc.	4008200310	marketing@tsbiochem.com	China	24644	58
Nantong QuanYi Biotechnology Co., Ltd	0513-66337626 18051384581	sales@chemhifuture.com	China	5018	58
Shanghai Yifei Biotechnology Co. , Ltd.	021-65675885 18964387627	customer_service@efebio.com	China	11974	58
R&D Systems, Inc	18003437475	rdname@qq.com	CHINA	35705	58
United States Biological	--	sales@advtechind.com	United States	6075	58

---

• CTA056
• 1,5-Dihydro-7-(phenylmethyl)-1-[3-(1-piperidinyl)propyl]-2-[4-(4-pyridinyl)phenyl]-6H-imidazo[4,5-g]quinoxalin-6-one
• CTA056 (CTA 056
• 6H-Imidazo[4,5-g]quinoxalin-6-one, 1,5-dihydro-7-(phenylmethyl)-1-[3-(1-piperidinyl)propyl]-2-[4-(4-pyridinyl)phenyl]-
• 1265822-30-7
• C35H34N6O